Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $38.4 million.

  • Medifast's Accounts Payables fell 3210.08% to $38.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $38.4 million, marking a year-over-year decrease of 3210.08%. This contributed to the annual value of $38.4 million for FY2025, which is 3210.08% down from last year.
  • Medifast's Accounts Payables amounted to $38.4 million in Q4 2025, which was down 3210.08% from $41.2 million recorded in Q3 2025.
  • Medifast's 5-year Accounts Payables high stood at $174.4 million for Q1 2022, and its period low was $38.4 million during Q4 2025.
  • In the last 5 years, Medifast's Accounts Payables had a median value of $104.2 million in 2023 and averaged $103.2 million.
  • Per our database at Business Quant, Medifast's Accounts Payables soared by 7973.94% in 2021 and then crashed by 4177.71% in 2025.
  • Medifast's Accounts Payables (Quarter) stood at $163.3 million in 2021, then fell by 17.52% to $134.7 million in 2022, then plummeted by 35.84% to $86.4 million in 2023, then crashed by 34.62% to $56.5 million in 2024, then crashed by 32.1% to $38.4 million in 2025.
  • Its last three reported values are $38.4 million in Q4 2025, $41.2 million for Q3 2025, and $40.3 million during Q2 2025.